Providing Comprehensive Care for Chronic and Life-Threatening Pediatric Conditions
Pediatric cancer and blood disorders remain a major challenge in Iraq due to limited resources, late diagnosis, and restricted access to specialized treatments. Under the guidance of Dr. Shaho Mohammed Aziz, the hospital’s Pediatric Hematology & Oncology department has implemented several new strategies to improve survival rates and treatment experiences for young patients.
Key Advancements in Pediatric Hematology & Oncology:
- Expanded Chemotherapy and Blood Transfusion Services: Increased capacity to treat childhood leukemia, sickle cell disease, and hemophilia, reducing the need for families to seek care abroad.
- Early Cancer Detection Programs: Improved diagnostic methods for detecting pediatric cancers such as leukemia, lymphoma, and neuroblastoma at earlier stages.
- Enhanced Bone Marrow Testing & Transplants: Offering advanced procedures to treat blood cancers and genetic blood disorders, reducing dependency on foreign medical institutions.
- Support Services for Families: Introducing counseling, nutritional guidance, and financial assistance programs to help families cope with the emotional and financial burden of childhood cancer.
- Collaboration with International Medical Institutions: Partnering with global pediatric cancer research centers to bring new treatment options and clinical trials to Iraq.
With these advancements, children battling blood disorders and cancer now have greater access to specialized treatments and improved chances of recovery.